TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15021 · Aug 1

#go#argocd#cloud_native#cncf#container_management#devops#ebpf#hacktoberfest#istio#jenkins#k8s#kubernetes#kubernetes_platform_solution#kubesphere#llm#multi_cluster#observability#servicemesh KubeSphere is an easy-to-use, open-source platform that helps you manage Kubernetes clusters across clouds, data centers, and edge devices from one place. It offers a friendly web interface, supports multi-cluster and multi-tenant management, and automates DevOps tasks like CI/CD pipelines. You get built-in monitoring, logging, alerting, and security features such as role-based access control. It also includes an App Store for quick deployment of applications and supports various storage and networking options. This makes managing complex Kubernetes environments simpler, faster, and more secure, saving you time and reducing operational challenges. https://github.com/kubesphere/kubesphere

Results

1 similar post found

Search: #rarediseases

当前筛选 #rarediseases清除筛选
America 🇺🇸 News & Politics

@America · Post #10378 · 03/12/2026, 06:00 AM

💊🇺🇸FDA APPROVES BREAKTHROUGH DRUGS FOR RARE DISEASES 🔹 Yuviwel approved Feb 27 for dwarfism growth — first-ever treatment for kids 👶 🔹 Loargys gets green light for ultra-rare Arginase 1 Deficiency 🧬 🔹 Bysanti breakthrough schizophrenia drug hits market February 20th 🧠 🔹 Wellcovorin approved March 10 for cerebral folate deficiency 🧪 🔹 Takeda's narcolepsy drug oveporexton submits for late March review 😴 5 novel drug approvals in first quarter — fastest pace since 2023! 📈 Rare disease patients get hope as FDA accelerates orphan drug pipeline... 🙏✨ #FDA#MedicalBreakthrough#RareDiseases#DrugApproval @america